Introduction
Although not adequately supported in the literature, large chronic subdural hematoma (CSDH) and substantial postoperative residual hematoma space are considered to be risk factors for developing postoperative recurrence [1] [2] [3] [4] [5] [6] . Traditionally, dimensions of the pre-and postoperative lesions have been assessed by computerized tomography (CT) scans using maximum in-plane thickness as a linear measurement. This has been a standard method employed to estimate CSDH size [1, 2, 5, [7] [8] [9] . Thus, over several decades, this linear estimate has been extensively discussed throughout the literature as a risk factor for postoperative recurrence, but the findings have been contradictory [1] [2] [3] [4] [5] [6] [9] [10] [11] [12] [13] [14] [15] [16] . Therefore, we hypothesized that approximation of CSDH size by linear measurement may be questionable. On the other hand, our recent study [16] showed that both large preoperative CSDH volume and large postoperative volume of residual hematoma space were radiological predictors of post-operative recurrence. Thus, current literature does not clearly define how to estimate and present neither the pre-nor the postoperative CSDH size. A study comparing 3D volumetric quantification of CSDH size and the linear measurement method has not yet been performed. Therefore, we conducted a prospective investigation in order to determine whether the thickness of CSDH could be used as a reasonable estimator of pre-and postoperative lesion size by comparing it with computer-assisted 3D volumetry estimation.
Methods
The study was approved by the Regional Ethical Committee of Health Region South-East Norway (S-06281a). Written and informed consent were obtained from patients or their close relatives prior to study inclusion.
Patient Population and Management
We prospectively investigated pre-and 1 st postoperative day CT scans, with and without contrast, of 107 adult patients with uni-or bilateral CSDHs who were surgically treated in the Department of Neurosurgery at Oslo University Hospital, during the time period January-December 2008. Hematoma evacuation was performed using a single burr-hole craniostomy and irrigation, followed by external, continuous closed-system drainage for a 24-hour period. The following radiological (CT scan) variables were analyzed: 1) site (unilateral or bilateral); 2) maximum in-plane thickness (pre-and postoperatively); 3) preoperative volume; and 4) postoperative residual cavity volume (i.e., the sum of residual rinsing fluid and residual air volumes in the hematoma cavity) following drain removal, on postoperative day one. Clinical data are not included because they are irrelevant to the subject matter of this study, which is lesion size quantification.
CSDHs were classified as unilateral or bilateral in site. The linear measurements, pre-and postoperative hematoma thickness, were estimated by measuring maximum in-plane thickness on each CT scan, at the level of CSDH; for unilateral CSDH the thickness of the one side was measured and for bilateral, the thicknesses of both sides were measured and the sum was determined [5, [7] [8] [9] 16] . Preoperative and postoperative CT scans were taken in order to estimate preoperative volume and residual cavity volume on postoperative day one, respectively, with the assistance of the software tool BrainVoyager QX 2.0. The method has been described previously [16] . In brief, images were electronically transferred in DICOM format to a workstation for image analysis. Preoperative CSDH and postoperative residual rinsing fluid in the hematoma cavity were delineated against soft tissues using the freehand selection tool on all tomographic images (slices), of each patient's CT scan. The area between the demarcation and the skull was filled using a seed-growing algorithm on each slice. Delineation of postoperative air content required no manual delineation due to excellent image contrast; and was performed using a manually placed starting point for each slice, and the same seed-growing algorithm as for the CSDH. Voxel dimensions from all individual slices and scans were extracted from the DI-COM image header and used to calculate total preoperative CSDH metric volumes, postoperative rinsing fluid and air volumes. Computer-assisted 3D volumetric quantifications of preoperative volume and postoperative volume of residual cavity; one side in unilateral, summation of both sides in bilateral hematomas; were considered the standard.
Statistical Analyses
Data were analyzed using mean (standard deviation) or number of patients (percentage) for continuous or categorical variables, respectively. Statistical analyses were performed using the independent sample t-test, Pearson correlation or chi-square test, as appropriate. All statistical analyses were conducted using PASW Statistics 18 (IBM Corporation, Armonk, New York, USA) and considered statistically significant if p-value < 0.05.
Results
The sample consists of the same 107 patients with CSDH whose CT characteristics and their relationship to postoperative recurrence are all published in our previous study [16] . In brief, there were 84 (78.5%) patients with unilateral and 23 (21.5%) with bilateral hematomas; 72 males (67.3%) and 35 females (32.7%); the mean age of males was 71.4 (12.2) and of females 73.6 (13.9) years.
Statistics portraying preoperative linear measurement of hematoma size and hematoma volume, postoperative linear measurement of residual hematoma cavity size and volume of residual hematoma cavity; in relation to gender and site of lesion are presented in Tables 1 and 2 , respectively. The correlations between the preoperative maximum thickness and the preoperative hematoma volume and between the postoperative maximum thickness of residual hematoma cavity and the postoperative residual hematoma cavity volume for the unilateral subgroup, bilateral subgroup and overall are shown in Table  3 . Pearson correlation coefficients between mean preand postoperative lesion thickness and mean pre-and postoperative lesion volume in the unilateral subgroup were 0.491 and 0.498, respectively; in the bilateral subgroup 0.505 and 0.579, respectively; and in the whole series 0.653 and 0.472, respectively.
As the colour-coded scatter-plot in Figure 1 shows, the preoperative maximum thickness of hematoma was an inaccurate estimator of the preoperative hematoma volume in an individual patient with unilateral or bilateral CSDHs. To give an example, an individual patient with unilateral CSDH who has a preoperative hematoma thickness of 27 mm may have the lower determined preoperative hematoma volume of 60 ml or the upper vol- ume of 225 ml; the difference is 165 ml if a linear relationship is assumed. As another example, an individual patient with bilateral CSDH who has a preoperative hematoma thickness of 37 mm may have the lower determined preoperative hematoma volume of 75 ml or the upper volume of 380 ml (305 ml range). It can be readily appreciated from Figure 2 that postoperative maximum thickness of residual hematoma cavity of an individual patient with unilateral or bilateral CSDHs was an inaccurate estimator of the postoperative lesion load, when compared to results from 3D volumetry. As an example, consider two patients with unilateral CSDH who had a 16 mm postoperative thickness of residual hematoma cavity; this could represent a 60 ml postoperative volume of residual hematoma cavity in the one and a volume of 240 ml in the other; the difference between them is then 180 ml if a linear relationship is assumed. Similarly, Figure 2 shows that an individual patient with bilateral CSDH who has a 22 mm postoperative thickness of residual cavity could have the lower determined postoperative volume of residual hematoma cavity of 130 ml or the upper volume of 308 ml (178 ml range).
Discussion
Preoperative hematoma thickness is considered to be an approximate, but reasonable indicator of the hematoma size and brain compression. Similarly, postoperative thickness is considered to be an approximate, but reasonable indicator of postoperative residual hematoma space size and postoperative brain decompression. Large preoperative hematoma thickness has repeatedly been reported to be associated with an increased risk of recurrence [1, 2, 13, 15] , corroborating a general opinion that a large CSDH is a risk factor for relapse; on the contrary, it has also repeatedly been reported that preoperative hematoma thickness is not associated with postoperative recurrence rate [4, 5, 9, 11, 12, 14, 16] . Similarly, it has been reported that large postoperative thickness of residual hematoma cavity is associated with an increased risk of recurrence [1] , corroborating a general opinion that persistence of residual space postoperatively may predispose to recurrence; on the contrary again, it has been reported that this radiological variable is not associated with recurrence rate [9, 16] . Given the contradictory nature of the aforementioned findings, it seems difficult to determine whether pre-and postoperative thickness is valid estimator of lesion load that should play any prognostic role in individual cases. Questions should be raised as to why the findings of previous studies have been conflicting and to what use we have of these controversial findings.
By virtue of a CSDH being an "old" circumscribed and liquefied collection of blood/ blood breakdown products encapsulated between the inner layer of the dura and the external surface of the brain at the arachnoid membrane, a CSDH can be sickle shaped and this is the basis for the linear measurement which is taken to approximate its size. However, the sickle shape of CSDH may vary considerably, depending on whether the lesion is located laterally over the hemisphere, if it extends to the cranial base, to the vertex or if it is interhemispheric. Furthermore, as Sucu et al. [17] have emphasized, axial CT slices above the superior temporal line are no longer perpendicular to the cranium or CSDH, instead they run virtually tangential to the hematoma because of the curvature of the cranial vault; therefore, the thickness of the hematoma measured on a slice close to vertex appears to be thicker than it actually is. Additionally, it is important to note that the method of measuring hematoma thickness is not standardized and varies between studies; in some studies thickness was measured on the CT scan at the level of its maximum in-plane thickness [5, [7] [8] [9] 16] and in others at the level of maximum in-plane thickness, at the level of lateral ventricles [1, 2] . Therefore, we hy-pothesized in this study that approximation of CSDH size by linear measurement is inexact and further that expressing lesion size in volumetric units could reduce the effect of approximations.
In this study, we found neither good correlations between the preoperative maximum thickness and the preoperative hematoma volume, nor between the postoperative maximum thickness and the postoperative volume of residual hematoma cavity in unilateral CSDH, bilateral CSDHs and in the entire series ( Table 3) . Judging from the scattered results shown in Figures 1 and 2 , the preand postoperative thickness of individual lesions in patients with unilateral or bilateral hematoma seem to be inaccurate estimators of the lesion volume when compared to 3D volumetry estimations; consequently, it seems that the pre-and postoperative hematoma thickness are not reliable estimators of pre-or postoperative lesion sizes.
In this study, we used computer-assisted volumetry derived from CT imaging, and found it to be quite an accurate method for quantification of preoperative hematoma size and postoperative size of residual hematoma cavity by virtue of the fact that it takes into consideration irregular lesion shape, different lesion density appearances and also includes each voxel in which the lesion appears. Additionally, the pre-and postoperative CSDH volume seems to be a more reasonable indicator of the preoperative brain compression and postoperative decompression than thickness. The results of this study reveal that quantification of pre-and postoperative lesion sizes based on computer-assisted 3D volumetry are inconsistent with quantification of sizes using linear measurements.
Currently, computer-assisted CSDH volumetry requires manual segmentation because no dedicated edgedetection software solutions exist for reliable delineation of the soft tissue boundaries created by CSDH, which is necessary in order to provide fully automated lesion volumetry. However, numerous disseminated software solutions are in existence and allow for straightforward semi-automatic volumetric assessments, as described in the current study. The extra time spent using 3D volumetry versus linear in-plane measurement is approximately 10 minutes per study; so, for merely 10 extra minutes, measurement that represents lesion size more accurately can be obtained.
Based on this prospective, single centre study including 107 patients with unilateral CSDH and bilateral CSDHs, it seems that pre-and postoperative thickness of CSDH do not offer reasonable approximations of the preand postoperative lesion size when compared to results from 3D volumetry in the unilateral subgroup, bilateral subgroup or in the entire series. Further, we speculate that volume should routinely be used as an estimator of pre-and postoperative lesion sizes in the determination of risk for postoperative recurrence. It seems that the linear measure of lesion size is outdated method for use for this purpose on account of the lack of their ability to assess lesion size correctly and predict postoperative recurrence consistently.
Conclusion
Pre-and postoperative lesion volumes were powerful estimators of the preoperative hematoma size and the postoperative size of residual CSDH cavity. Pre-and postoperative maximum in-plane thickness of hematoma does not offer reasonable approximations of the pre-and postoperative lesion size. The results of this study may help identify useful radiological tools that could be of assistance in both the optimal clinical decision-making and the determination of risk of postoperative CSDH recurrence.
